AI-generated draft from CMS source. Review and verify clinical accuracy before use.

CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention phase following documented failure of conventional behavioral, pharmacologic, and/or surgical therapy for urinary urge incontinence, urgency-frequency syndrome, urinary retention, or fecal incontinence. The patient has demonstrated successful test stimulation with at least 50% improvement in symptoms, supporting progression to permanent peripheral sacral neurostimulator pulse generator implantation.

– Sequencing logic:
Typically, the procedure follows initial conservative care and successful percutaneous test stimulation demonstrating symptom improvement before permanent implantation is considered.

ICD-10 / DIAGNOSIS SUPPORT
Diagnoses supporting sacral neurostimulator pulse generator implantation include urinary urge incontinence, urgency-frequency syndrome, urinary retention, and chronic fecal incontinence not attributable to neurologic diseases, anorectal malformations, or chronic inflammatory bowel disease. The documented diagnoses correlate with clinical presentation, functional impairment, and prior treatment failure.

– Example ICD-10 options:
N39.41 – Urge incontinence
N39.46 – Mixed incontinence
N39.490 – Overflow incontinence
R15.9 – Full incontinence of feces
N30.10 – Interstitial cystitis (chronic) without hematuria

SUBJECTIVE / HPI SUPPORT
Patient reports persistent urinary urge incontinence, urgency-frequency syndrome, urinary retention, or chronic fecal incontinence characterized by frequent uncontrolled episodes occurring despite comprehensive conservative management. Symptoms have persisted for greater than six months and interfere with daily activities including hygiene, sleep, and work.

– Edit if needed:
greater than 6 months duration
incontinence frequency greater than two episodes per week
associated urgency and frequency

CONSERVATIVE CARE / PRIOR TREATMENT
Patient has undergone documented failure or intolerance to appropriate conservative therapies including behavioral interventions, dietary modifications, pharmacologic treatments, and prior surgery when applicable.

– Common conservative care examples:
Behavioral therapy such as bladder training or biofeedback
Pharmacologic management including anticholinergics or other relevant agents
Dietary modification and bulking agents for fecal incontinence

OBJECTIVE / DIAGNOSTIC SUPPORT
Clinical evaluation and voiding or bowel diaries document symptom severity and impairment. Test stimulation of sacral nerves has demonstrated at least 50% sustained improvement in symptoms lasting more than one week, supporting medical necessity for permanent device implantation. Available imaging and exam findings exclude alternative conditions such as neurologic diseases or anatomical abnormalities that would preclude successful therapy.

ASSESSMENT
Assessment: Chronic urinary urge incontinence, urgency-frequency syndrome, urinary retention, or fecal incontinence refractory to conservative therapy and with documented successful sacral nerve test stimulation demonstrating significant symptom improvement. The patient is an appropriate candidate for permanent implantation of a peripheral sacral neurostimulator pulse generator.

PLAN / NEXT STEP
Plan: Proceed with insertion or replacement of peripheral sacral neurostimulator pulse generator requiring pocket creation and connection with existing electrode array. The procedure will target the appropriate nerve root(s) based on prior successful test stimulation and clinical findings. Risks, benefits, and alternatives have been reviewed with the patient.

– Edit if needed:
right-sided implantation
left-sided implantation
bilateral implantation

PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
Patient has undergone a successful percutaneous test stimulation with sustained symptom improvement of 50% or more, as documented by voiding or bowel diaries. Patient’s condition is not related to excluded neurologic or anatomical conditions. Patient demonstrates ability to comply with device management and symptom monitoring.

– Documentation tip:
Include symptom severity scores pre- and post-test stimulation, duration of relief, and functional impact assessments.

FOLLOW-UP / RESPONSE DOCUMENTATION
Patient reports meaningful and sustained improvement in incontinence episodes, urgency frequency, retention symptoms, or fecal continence following device implantation. Improvement is corroborated by objective diary data and enhanced quality of life measures. No significant adverse events or complications have been observed to date.

– Edit if needed:
greater than 50% symptom improvement
sustained relief lasting several months or longer

MISSING DOCUMENTATION CHECK
– Documentation items to confirm before procedure scheduling:
Symptom duration and frequency
Functional limitation and impact on daily living
Detailed prior conservative treatment and response
Successful test stimulation results
Patient’s ability to maintain symptom diaries
Exclusion of contraindicated conditions such as neurologic diseases or anatomical defects
Relevant ICD-10 diagnoses

APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested peripheral sacral neurostimulator pulse generator insertion is clinically supported by the patient’s refractory symptoms of urinary or fecal incontinence, documented functional impairment, exclusion of contraindicated conditions, and a successful test stimulation demonstrating significant symptom improvement. The treatment plan aligns with established care pathways and clinical guidelines supporting progression to permanent implantation.